Pervasive Health was founded in 2012, but the company was renamed Apervita on Jan. 1.
Apervita is a health analytics and data marketplace. Shortly after adopting its new name, the company completed an $18 million Series A round of funding. GE Ventures and Baird Capital led the financing round. Pritzker Group, Venture Capital Math Ventures and existing investors also participated.
The company has 40 employees, but that number is expected to grow. Apervita has already drawn attention from the healthcare industry. In February, partners and providers HealthXL, a global clearinghouse for healthcare innovation, voted Apervita the "most likely to make the biggest immediate impact on digital health."
Near the end of February, Mayo Clinic in Rochester, Minn., announced it would use Apervita to commercialize its analytics.
Apervita is led by co-founder and CEO Paul Magelli.